Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure
Fumihiro Ito,
Koki Kobayashi,
Gaku Hayashi,
Shunsuke Kamijo,
Takashi Fujita IJU Case Reports
· Wiley
· 2026-09-27
· DOI: 10.1002/iju5.70276
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Fumihiro Ito, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Takashi Fujita. Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure. // IJU Case Reports. – 2026. – DOI: 10.1002/iju5.70276. – URL: https://onlinelibrary.wiley.com/doi/10.1002/iju5.70276?af=R
Fumihiro Ito, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, & Takashi Fujita (2026). Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure. IJU Case Reports. https://doi.org/10.1002/iju5.70276
Fumihiro Ito, et al. “Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure.” IJU Case Reports, 2026. doi:10.1002/iju5.70276.
@article{Ito2026,
title = {Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure},
author = {Ito, Fumihiro and Kobayashi, Koki and Hayashi, Gaku and Kamijo, Shunsuke and Fujita, Takashi},
journal = {IJU Case Reports},
year = {2026},
doi = {10.1002/iju5.70276},
url = {https://onlinelibrary.wiley.com/doi/10.1002/iju5.70276?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...